Provectus Biopharmaceuticals begins recruitment for phase 2 mechanism of action clinical trial of PH-10 for psoriasis

Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company ('Provectus'), has announced that it has opened recruitment for its phase 2 mechanism...